Tag: development agreement

September 20, 2018

Applied DNA Subsidiary LineaRx Enters New Partnership

Applied DNA Sciences subsidiary LineaRx, along with Takis and Evvivax, has engaged in a new development agreement.
September 20, 2018

Applied DNA Subsidiary, LineaRx Signs Joint Development Agreement with Takis and Evvivax

Applied DNA Sciences (NASDAQ:APDN) announced that LineaRx its wholly-owned subsidiary focused on next-generation biotherapeutics, has signed a Joint Development Agreement with...